Rox-CR (Paroxetine) 12.5mg & 25mg Tablets

Rox-CR (Paroxetine) Controlled Release Tablets: Comprehensive First-Line Therapy for Mood and Anxiety

Navigating chronic mood and anxiety disorders requires a reliable, comprehensive therapeutic solution. Rox-CR (Paroxetine) 12.5mg and 25mg controlled-release tablets are highly recommended by international guidelines as a first-line intervention. By combining standard-setting efficacy with an innovative controlled-release mechanism, Rox-CR delivers consistent, stable relief to help patients successfully manage their mental well-being.

• Broadest FDA Approval in its Class: Rox-CR stands out as the only SSRI of its class approved by the FDA for all five major Anxiety Disorders as well as Major Depressive Disorder (MDD).

• Targeted Trauma & Panic Support: Clinical data proves that Rox-CR ensures a significant reduction in panic attacks compared to alternative antidepressants. Additionally, it is found to be highly safe and effective in treating adults with Post-Traumatic Stress Disorder (PTSD).

• Rapid Action: Designed to improve patient outlook quickly, Rox-CR lifts mood faster than other standard SSRIs.

• Advanced Gastric Comfort: Rox-CR features the distinct advantage of not disintegrating in the stomach. By bypassing stomach dissolution, it directly decreases gastrointestinal adverse events, enhancing overall tolerability and long-term compliance.

• Fewer Side Effects & Interactions: Patients benefit from a cleaner therapeutic profile, as Rox-CR demonstrates a lower incidence of general adverse effects and drug interactions.